HSBA

877.4

-0.76%↓

BARC

336.85

+0.55%↑

LLOY

76.76

+0.92%↑

RBS

507.4

-0.08%↓

FLTR.UK

19,765

+0.46%↑

HSBA

877.4

-0.76%↓

BARC

336.85

+0.55%↑

LLOY

76.76

+0.92%↑

RBS

507.4

-0.08%↓

FLTR.UK

19,765

+0.46%↑

HSBA

877.4

-0.76%↓

BARC

336.85

+0.55%↑

LLOY

76.76

+0.92%↑

RBS

507.4

-0.08%↓

FLTR.UK

19,765

+0.46%↑

HSBA

877.4

-0.76%↓

BARC

336.85

+0.55%↑

LLOY

76.76

+0.92%↑

RBS

507.4

-0.08%↓

FLTR.UK

19,765

+0.46%↑

HSBA

877.4

-0.76%↓

BARC

336.85

+0.55%↑

LLOY

76.76

+0.92%↑

RBS

507.4

-0.08%↓

FLTR.UK

19,765

+0.46%↑

Search

Reckitt Benckiser Group PLC

Atvērts

SektorsFinanšu

4,971 -0.74

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4956

Max

5004

Galvenie mērījumi

By Trading Economics

Ienākumi

1.1B

Pārdošana

-3.7B

3.5B

P/E

Sektora vidējais

24.755

24.617

EPS

1.61

Dividenžu ienesīgums

3.95

Peļņas marža

15.934

Darbinieki

37,900

EBITDA

889M

2.8B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+14.4% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.95%

4.23%

Nākamie ieņēmumi

2025. g. 24. jūl.

Nākamais dividenžu datums

2025. g. 12. sept.

Nākamais Ex dividenžu datums

2025. g. 31. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-3.4B

34B

Iepriekšējā atvēršanas cena

4971.74

Iepriekšējā slēgšanas cena

4971

Ziņu noskaņojums

By Acuity

70%

30%

482 / 538 Rangs Finance

Reckitt Benckiser Group PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 12. jūn. 05:41 UTC

Iegādes, apvienošanās, pārņemšana

Reckitt Benckiser in Exclusive Talks With Advent Over Sale of Essential Home Business, Reuters Says, Citing Sources

2025. g. 23. apr. 10:52 UTC

Peļņas

Lysol Maker Reckitt Warns Choppy Markets Might Delay Home-Care Exit -- 2nd Update

2025. g. 23. apr. 07:18 UTC

Peļņas

Lysol Maker Reckitt Says Market Conditions Might Delay Home-Care Exit -- Update

2025. g. 23. apr. 06:38 UTC

Peļņas

Lysol Maker Reckitt Confident of Mitigating Tariff Impact

2025. g. 14. marts 19:47 UTC

Galvenie tirgus virzītāji

Correction to Reckitt Shares Drop on Infant Formula Retrial Article

2025. g. 14. marts 14:52 UTC

Galvenie tirgus virzītāji

Reckitt Shares Drop on Infant Formula Retrial in U.S.

2025. g. 30. maijs 13:47 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Consumer Health Sector Has Room for More Dealmaking -- Market Talk

2025. g. 30. maijs 08:21 UTC

Tirgus saruna
Peļņas

Reckitt's Work on Portfolio Is Starting to Pay off -- Market Talk

2025. g. 23. apr. 12:08 UTC

Tirgus saruna
Peļņas

Reckitt Update Might Raise Doubts About Full-Year Guidance -- Market Talk

2025. g. 23. apr. 12:05 UTC

Tirgus saruna
Peļņas

Reckitt Might Be Wise to Consider Spinoff, IPO for Home-Care Unit -- Market Talk

2025. g. 23. apr. 09:05 UTC

Karstas akcijas

Stocks to Watch Wednesday: Tesla, SAP, Boeing -- WSJ

2025. g. 23. apr. 09:03 UTC

Tirgus saruna
Peļņas

Reckitt Outlook Clouded by Potential Delays to Transformation -- Market Talk

2025. g. 23. apr. 07:43 UTC

Tirgus saruna
Peļņas

Reckitt's Essential Home Weakness Raises Questions -- Market Talk

2025. g. 23. apr. 06:06 UTC

Peļņas

Reckitt: Core Reckitt Growth to Be More Balanced Across All Three Regions in 2H

2025. g. 23. apr. 06:06 UTC

Peļņas

Reckitt: Core Reckitt Growth to Be Led by Emerging Markets in 2Q

2025. g. 23. apr. 06:05 UTC

Peļņas

Reckitt: Confident in Mitigating Tariff Impact on Costs Over Short to Midterm

2025. g. 23. apr. 06:05 UTC

Peļņas

Reckitt: Latest Modelling Identifies Immaterial Annualized Impact on Cost Base

2025. g. 23. apr. 06:04 UTC

Peļņas

Reckitt Monitoring Potential Tariff Impact on Supply Chain, Cost Base

2025. g. 23. apr. 06:04 UTC

Peļņas

Reckitt Closely Monitoring Evolving Situation Around Global Tariffs

2025. g. 23. apr. 06:03 UTC

Peļņas

Reckitt Still Targets 3%-4% Like-for-Like Net Revenue Growth in Core Segment for 2025

2025. g. 23. apr. 06:03 UTC

Peļņas

Reckitt Still Expects 2025 Like-for-Like Net Revenue Growth of 2% to 4%

2025. g. 23. apr. 06:02 UTC

Peļņas

Reckitt Backs 2025 Outlook

2025. g. 23. apr. 06:02 UTC

Peļņas

Reckitt Mead Johnson 1Q Like-for-Like Net Revenue Declined 0.5%

2025. g. 23. apr. 06:02 UTC

Peļņas

Reckitt Essential Home 1Q Like-for-Like Net Revenue Fell 7%

2025. g. 23. apr. 06:01 UTC

Peļņas

Reckitt Core Segment 1Q Like-for-Like Net Revenue Growth 3.1%

2025. g. 23. apr. 06:01 UTC

Peļņas

Analysts Saw Reckitt 1Q Like-for-Like Net Revenue Growth at 1.4%

2025. g. 23. apr. 06:01 UTC

Peļņas

Analysts Saw Reckitt 1Q Net Revenue at GBP3.69B

2025. g. 23. apr. 06:01 UTC

Peļņas

Reckitt 1Q Rev GBP3.68B

2025. g. 23. apr. 06:00 UTC

Peļņas

Reckitt 1Q Like-for-Like Net Revenue Growth 1.1%

2025. g. 6. marts 12:47 UTC

Tirgus saruna
Peļņas

Reckitt Benckiser Delivers Messy Performance, AJ Bell Says -- Market Talk

Salīdzinājums

Cenas izmaiņa

Reckitt Benckiser Group PLC Prognoze

Cenas mērķis

By TipRanks

14.4% augšup

Prognoze 12 mēnešiem

Vidējais 5,754.55 GBX  14.4%

Augstākais 7,700 GBX

Zemākais 4,900 GBX

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Reckitt Benckiser Group PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

8

Pirkt

6

Turēt

0

Pārdot

Noskaņojums

By Acuity

482 / 538 Rangs Finanšu

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Reckitt Benckiser Group PLC

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.